Loading chat...

HI HB1133

Bill

Status

Introduced

1/23/2025

Primary Sponsor

Nadine Nakamura

Click for details

Origin

House of Representatives

2026 Regular Session

AI Summary

  • Adds 15 new synthetic opioids to Schedule I controlled substances, including brorphine, metonitazene, protonitazene, and various fentanyl analogs (alpha'-methyl butyryl fentanyl, ortho-fluorofuranyl fentanyl, para-methoxyfuranyl fentanyl, and others)

  • Adds two new hallucinogenic substances to Schedule I: eutylone (bk-EBDB) and zipeprol

  • Adds four new stimulants to Schedule I: amineptine, mesocarb, and methiopropamine, while reorganizing the existing stimulant list numbering

  • Adds zuranolone as a new Schedule IV depressant and removes the separate subsection for fenfluramine, consolidating the schedule structure

  • Updates Hawaii Revised Statutes Chapter 329 to align with federal Controlled Substances Act amendments as required under section 329-11, HRS, effective upon approval

Legislative Description

Relating To The Uniform Controlled Substance Act.

Last Action

Carried over to 2026 Regular Session.

12/8/2025

Committee Referrals

Health1/23/2025

Full Bill Text

No bill text available